Increase in availability of online topical pain relief products is anticipated to fuel the market growth during the forecast period.

PORTLAND, OR, UNITED STATES, October 13, 2020 /EINPresswire.com/ -- UPDATE AVAILABLE ON-DEMAND

According to the report by Allied Market Research, the U.S. Topical Pain Relief market is estimated to register a CAGR of 6.0% from 2018 to 2025. The research helps leading players and startups to devise new strategies based on current market trends and changing dynamics. Competitive landscape is mentioned in the report based on business segments, products portfolio, and strategic moves & developments of leading market players. Detailed segmentation assists in determining growing segments and determining further steps to capitalize on lucrative segments. Regional landscape is helpful in determining opportunities and driving factors of each region and taking further steps.

The market report includes a detailed analysis of the Covid-19 impact on the Topical pain relief market. Over the course of 2019–2027, the market is expected to show significant growth. However, the recent Covid-19 outbreak is likely to affect some of the business operations. The report includes an analysis of how Covid-19 has and will affect the industry, studying reliable sources, interviews of experts, and annual reports of the major market players. The report includes major drivers, restraints, and opportunities within the Topical pain relief market.

To Get the Sample Copy of Report Visit @ https://www.alliedmarketresearch.com/request-sample/5356

Upsurge in prevalence of arthritis, rise in demand for topical pain relief products from sportspeople, and fewer side effects as compared to oral medicines drive the growth in the U.S. topical pain relief market. However, side effects such as skin irritation and unpleasant odor of the products restrain the market growth. On the other hand, emergence of online pharmacy present new opportunities in the industry.

Non-opioids segment to be lucrative by 2025

Based on therapeutic class, the non-opioids segment accounted for nearly three-fourths of the total share in 2017 and is expected to contribute its lion's share by 2025. Moreover, this segment is expected to register the highest CAGR of 6.2% during the forecast period, 2018–2025. It is a lucrative segment due to preference over the opioid drugs to treat mild to moderate pain and lesser side effects in comparison to opioids. The research also analyzes the opioids segment.

Inquire Before Buying @ https://www.alliedmarketresearch.com/purchase-enquiry/5356

Cream segment to maintain its dominance during the forecast period

On the basis of formulation, the cream segment held the major share in 2017, accounting for nearly two-fifths of the total market share, and is expected to maintain its dominance during the forecast period. This is attributed to help in offering long-lasting comfort and quick pain relief without irritating or burning skin along with lack of risk of side effects and prevention of intake of oral narcotics. However, the patch segment would grow at the highest CAGR of 7.6% from 2018 to 2025, owing to uniform plasma drug concentrations and controlled absorption provided by patches along with rise in preference to relieve minor to severe pain.

Pharmacies & drug stores segment to continue its leadership status by 2025

Based on distribution channels, the pharmacies & drug stores segment dominated the market share, with nearly fourth-fifths of the total revenue in 2017, and is expected to continue its leadership status by 2025. This is due to ease in availability of a diverse set of drugs and services at different outlets. On the other hand, the e-commerce segment would register the highest growth rate, with a CAGR of 8.7% from 2018 to 2025, owing to significant rise in digital literacy among the population, fewer expenses, enhanced convenience, and ease in access to patient reviews.

Access Full Report @ https://www.alliedmarketresearch.com/us-topical-pain-relief-market

The Major Key Players Are:

Johnson & Johnson, Novartis AG, GlaxoSmithKline Plc., Pfizer Inc., Reckitt Benckiser Group Plc., Sanofi S.A., Topical BioMedics, Inc., AdvaCare Pharma, Sun Pharmaceutical Industries Ltd., and Nestle S.A.

Similar Reports:

Topical Drug Delivery Market Analysis and Industry Forecast, 2027

Non-opioid Pain Patch Market Analysis and Industry Forecast, 2027

UK IVD Market Analysis and Industry Forecast, 2027

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn